Patients Hospitalized With COVID-19 Face Higher Long-Term Risk for Death, Rehospitalization
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 28, 2025 -- Individuals previously hospitalized for COVID-19 have an increased risk for subsequent death or hospitalization for various organ disorders up to 30 months after discharge, according to a study published online Feb. 28 in Infectious Diseases.
Sarah Tubiana, Pharm.D., from Université Paris Cité, and colleagues used French claims data to compare all-cause mortality and organ disorder-related hospitalization among 63,990 individuals hospitalized for COVID-19 between Jan. 1 and Aug. 30, 2020, versus 319,891 controls from the general population not hospitalized for COVID-19.
During 30 months of follow-up, the researchers found that the weighted cumulative incidences of all-cause mortality and hospitalization were 5,218 per 105 person-years (PY) and 16,334 per 105 PY, respectively, among those with COVID-19 hospitalization compared with 4,013 and 12,095 per 105 PY, respectively, among controls. Individuals hospitalized for COVID-19 were more likely to be subsequently hospitalized for cardiovascular, psychiatric, neurological, and respiratory events (incidence rate ratios, 1.22, 1.41, 1.50, and 1.99, respectively). While the excess risk strongly decreased after the first six months for all outcomes, risk remained significantly increased up to 30 months for neurological disorders, respiratory disorders, chronic renal failure, and diabetes.
"While much attention has been given to the immediate dangers of the virus, our research shows that hospitalized COVID-19 survivors remain at greater risks of severe health complications months and even years later," Tubiana said in a statement. "The long-term implications for public health are significant."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Further Support and Information on COVID-19
Read this next
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease
MONDAY, June 23, 2025 -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.